Clinical Trial

Potential of Moderate Whole Body Hyperthermia to Enhance Response

Name: Potential of Moderate Whole Body Hyperthermia to Enhance Response — clinical trial record (NCT05821166)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: POWER

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

Using moderate whole-body hyperthermia (mWBH) in tumor patients to see the influence on circulating tumor cells, tumor response, quality of life, fatigue, psyche, immune response and tumor microenvironment

Trial Details

NCT Number	NCT05821166
Lead Sponsor	Charite University, Berlin, Germany
Conditions	Oncology
Enrollment	80 participants
Start Date	2023-02-01
Primary Completion	2026-12-01 (estimated)
Study Completion	2027-12-01 (estimated)
Updated on ClinicalTrials.gov	2023-04-20